Background & Aims Liver stiffness measurements (LSMs) provide an opportunity to monitor
liver disease progression and regression noninvasively. We aimed to determine the …

Chronic liver disease is a major cause of morbidity and mortality worldwide. Epidemiology,
clinical phenotype and response to therapies for gastrointestinal and liver diseases are …

Introduction As a common autoimmune disease with the characteristic of early complication,
primary biliary cholangitis (PBC) leads to an increasing number of mortalities among people …

Etiological cure prevents further decompensation and mortali... : Hepatology Etiological cure
prevents further decompensation and mortality in patients with cirrhosis with ascites as the single …

Background Aetiological therapy improves liver function and may enable hepatic
recompensation in decompensated cirrhosis. Aims We explored the potential for …

Background Suboptimal response to ursodeoxycholic acid occurs in 40% of primary biliary
cholangitis (PBC) patients, affecting survival. Achieving a deep response (normalisation of …

Primary biliary cholangitis (PBC) is a rare chronic autoimmune-mediated cholestatic liver
disease involving medium and small bile ducts that can lead to liver fibrosis and cirrhosis. To …

Objectives Spleen stiffness measurement (SSM) provides a non-invasive surrogate marker
for clinical significant portal hypertension (CSPH). Results obtained in highly selected …

Abstract Objectives The Baveno VII consensus recommends endoscopic screening for
varicose veins in cases of liver stiffness measurement (LSM)≥ 20 kPa or platelet count≤ …

Background Our study aimed to analyze the characteristics of ultrasound images
corresponding to each histological stage of primary biliary cholangitis (PBC). Methods We …